Phase III Confirmatory Study in Erythropoietic Protoporphyria

NCT01605136 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Erythropoietic Protoporphyria

Interventions

DRUG: Afamelanotide
DRUG: Placebo

Sponsor

Clinuvel Pharmaceuticals Limited